ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial
Takashi Akiyoshi(The Japanese Society of Gastroenterological Surgery), Kensei Yamaguchi(Japanese Foundation For Cancer Research), Antony Tin(Natera (United States)), Adham Jurdi(University of the Incarnate Word), Tetsuro Tominaga(Nagasaki University Hospital), Minetta C. Liu(Mayo Clinic), Kohei Shigeta(Keio University), Shimpei Matsui(Keio University), Yutaka Hanaoka(Toranomon Hospital), Toshiki Mukai(Japanese Foundation For Cancer Research), Senzo Taguchi(Japanese Foundation For Cancer Research), Shigeo Toda(Toranomon Hospital), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Hiroki Osumi(The Cancer Institute Hospital), Naoki Miyazaki(Keio University Hospital), Erik Spickard(Natera (United States)), Akiko Chino(Japanese Foundation For Cancer Research), Eiji Shinozaki(Japanese Foundation For Cancer Research), Yusuke Maeda(Toranomon Hospital), Shuichiro Matoba(Toranomon Hospital), Koji Okabayashi(Keio University)
Cited by 13
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707